Biotech Breakthrough: Big Moves in Heart Disease Treatment
Cytokinetics Surges with Strategic Licensing in China Cytokinetics, a biotech company headquartered in California, witnessed an impressive rise in its stock price, climbing nearly 5% on Friday—surpassing the modest growth of the S&P 500 index. This surge followed the announcement of a
